Cerevel

Cerevel Therapeutics Holdings is a biopharmaceutical company focused on developing therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of neuroscience therapies, which include clinical-stage compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia, and addiction.